Galectin-9: diverse roles in skin disease

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Galectin-9 (Gal-9) is a key immunomodulator influencing cell processes and interacting with receptors like Tim-3.
• Gal-9's role is increasingly recognized in autoimmune diseases, tumor microenvironments, and viral infections.
• Circulating Gal-9 levels correlate with disease progression in infectious and potentially skin conditions.

Purpose of the Study:

• To review current research on Gal-9's immunomodulatory functions in various skin diseases.
• To explore Gal-9's potential as a diagnostic biomarker for dermatological conditions.
• To provide a reference for future research on Gal-9 in skin pathophysiology and therapeutics.

Main Methods:

• Literature review of studies on Gal-9 in dermatological contexts.
• Analysis of Gal-9's involvement in immune homeostasis and disease pathophysiology.
• Consideration of mouse model validation using exogenous Gal-9.

Main Results:

• Gal-9 plays a significant role in the pathophysiology of numerous skin diseases, including chronic spontaneous urticaria, lupus, atopic dermatitis, melanoma, and psoriasis.
• Altered Gal-9 levels are observed in various dermatoses, indicating its clinical relevance.
• Exogenous Gal-9 demonstrated effects in a mouse model, supporting its functional significance.

Conclusions:

• Galectin-9 is a critical regulator of immune homeostasis with altered levels in many skin diseases.
• Gal-9 shows promise as a sensitive and noninvasive biomarker for assessing dermatosis severity.
• Further research is needed to fully elucidate Gal-9's role and therapeutic potential in skin diseases.